As of 2025-09-18, the Relative Valuation of Alliance Pharma PLC (APH.L) is (25.16) GBP. This relative valuation is based on P/E multiples. With the latest stock price at 64.70 GBP, the upside of Alliance Pharma PLC based on Relative Valuation is -138.9%.
The range of the Relative Valuation is (23.21) - (28.67) GBP.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 9.7x - 14.7x | 11.8x |
| Forward P/E multiples | 11.9x - 15.6x | 14.0x |
| Fair Price | (23.21) - (28.67) | (25.16) |
| Upside | -135.9% - -144.3% | -138.9% |
| Date | P/E |